Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 3, 2012Diabetes Obesity and Metabolism

Treatment persistence, hypoglycaemia and clinical outcomes in type 2 diabetes patients with dipeptidyl peptidase‐4 inhibitors and sulphonylureas: a primary care database analysis

View Full Paper
Ask AI
Bookmark
Share

Authors

WRWolfgang RathmannInnsbruck Medical UniversityKKKarel KostevPhilipps University of MarburgJGJ.B. GruenbergerNovartis (Switzerland)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Rathmann et al. (2012) studied this question.

synapsesocial.com/papers/6a20d09210699ec7be2a94eahttps://doi.org/10.1111/j.1463-1326.2012.01674.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review2007 · 492 citations
  2. 2Medication Adherence in Type 2 Diabetes: The ENTRED Study 2007, a French Population-Based Study2012 · 248 citations
  3. 3Glucose lowering and anti-atherogenic effects of incretin-based therapies: GLP-1 analogues and DPP-4-inhibitors2009 · 83 citations
  4. 4Validity and representativeness of the “Disease Analyzer” patient database for use in pharmaco-epidemiological and pharmacoeconomic studies2009 · 244 citations
  5. 5Comparisons of Persistence and Durability Among Three Oral Antidiabetic Therapies Using Electronic Prescription-Fill Data: The Impact of Adherence Requirements and Stockpiling2011 · 37 citations